BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20544193)

  • 1. PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.
    Mertens K; Slaets D; Lambert B; Acou M; De Vos F; Goethals I
    Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2188-93. PubMed ID: 20544193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
    Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
    BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
    Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
    Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review.
    Treglia G; Giovannini E; Di Franco D; Calcagni ML; Rufini V; Picchio M; Giordano A
    Ann Nucl Med; 2012 Jul; 26(6):451-61. PubMed ID: 22566040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition with (11)C-choline and (18)F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.
    von Eyben FE; Kairemo K
    Ann Nucl Med; 2016 Jul; 30(6):385-92. PubMed ID: 27173771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer imaging with fluorine-18-labeled choline derivatives.
    Kwee SA; DeGrado TR; Talbot JN; Gutman F; Coel MN
    Semin Nucl Med; 2007 Nov; 37(6):420-8. PubMed ID: 17920349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-phase (18)F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan.
    Tong AK; Zhang ZX; Zaheer S; Yan XS
    Clin Imaging; 2016; 40(3):486-91. PubMed ID: 27133692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates.
    Krause BJ; Souvatzoglou M; Treiber U
    Urol Oncol; 2013 May; 31(4):427-35. PubMed ID: 21388835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
    Poncet D; Arnoux V; Descotes JL; Rambeaud JJ; Verry C; Terrier N; Boillot B; Dubreuil J; Lanchon C; Carnicelli D; Fiard G; Long JA
    Prog Urol; 2015 May; 25(6):325-30. PubMed ID: 25748788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT.
    Beheshti M; Rezaee A; Geinitz H; Loidl W; Pirich C; Langsteger W
    J Nucl Med; 2016 Oct; 57(Suppl 3):55S-60S. PubMed ID: 27694173
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
    Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
    J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.
    Kwee SA; Ko JP; Jiang CS; Watters MR; Coel MN
    Radiology; 2007 Aug; 244(2):557-65. PubMed ID: 17581887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
    Bauman G; Belhocine T; Kovacs M; Ward A; Beheshti M; Rachinsky I
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):45-55. PubMed ID: 21844889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation dosimetry of 18F-fluorocholine PET/CT studies in prostate cancer patients.
    Fabbri C; Galassi R; Moretti A; Sintuzzi E; Mautone V; Sarti G; Strigari L; Benassi M; Matteucci F
    Phys Med; 2014 May; 30(3):346-51. PubMed ID: 24238928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.
    Fanti S; Minozzi S; Castellucci P; Balduzzi S; Herrmann K; Krause BJ; Oyen W; Chiti A
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):55-69. PubMed ID: 26450693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Kwee SA; Sato MM; Kuang Y; Franke A; Custer L; Miyazaki K; Wong LL
    Mol Imaging Biol; 2017 Jun; 19(3):446-455. PubMed ID: 27787742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.